Download PDF
CC BY-NC-ND 4.0 · South Asian J Cancer 2018; 07(01): 37-41
DOI: 10.4103/sajc.sajc_240_17
ORIGINAL ARTICLE: Genitourinary & Gynaecological Cancer

Translation and validation of European Organization for Research and Treatment for Cancer quality of life questionnaire-OV-28 module into Indian languages (Hindi and Marathi) to study quality of life of ovarian cancer patients from a tertiary care cancer center

Jyoti Bajpai
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra
,
Pankaj Kumar Panda
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra
,
Shraddha Kagwade
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra
,
Madhavi Govilkar
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra
,
Shruti Velaskar
Department of Occupational therapy, Tata Memorial Hospital, Mumbai, Maharashtra
,
Yogesh Kembhavi
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra
,
Sudeep Gupta
Department of Palliative Medicine, Tata Memorial Hospital, Mumbai, Maharashtra
,
Jaya Ghosh
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra
,
Jayita Deodhar
Department of Palliative Medicine, Tata Memorial Hospital, Mumbai, Maharashtra
› Author Affiliations Financial support and sponsorship Nil.
› Further Information
  PDF Download Permissions and Reprints

Abstract

Aim: The aim is to translate and validate the European Organization for Research and Treatment for Cancer (EORTC) ovarian cancer (OC) module (OV-28) into Hindi and Marathi to use for patients and scientific community. Methods and Results: The EORTC OV-28 was translated into Hindi and Marathi languages using prescribed guidelines by the EORTC. The process included forward translation by four translators (2 each for Hindi and Marathi). The questionnaires obtained were then given to independent backward-translators who then translated them back into English. These 2 questionnaires were then compared with the original EORTC questionnaire and the second intermediate questionnaires were formed. The second intermediate questionnaire was subsequently administered in twenty patients (10 each for Hindi and Marathi) diagnosed with OC who had never seen the questionnaire before, for pilot testing. Each of these ten patients after filling up the questionnaire themselves was then interviewed for any difficulty encountered during the filling up of the questionnaires. These were in the form of specific modules including difficulty in answering, confusion while answering, and difficulty to understand, whether the questions were upsetting and if patients would have asked the question in any different way. The suggestions were incorporated into the second intermediate questionnaires to form the final Hindi and Marathi ON-28 questionnaires. These questionnaires were then sent to the EORTC for the final approval to be used in clinical studies. Conclusion: We have successfully translated EORTC OV-28 module into Hindi and Marathi languages, and EORTC approved them to be used in clinical practice and studies for OC patients.

Key words

European Organization for Research and Treatment for Cancer - OV-28 - ovarian cancer - quality of life - questionnaire


Publication History

Article published online:
22 December 2020

© 2018. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. International Agency for Research on Cancer. GLOBOCAN 2012 v1.0. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Available from: http://www.Globocan.iarc.fr. [Last accessed on 2013 Dec 12].
  • 2 Takiar R, Nadayil D, Nandakumar A. Projections of number of cancer cases in India (2010-2020) by cancer groups. Asian Pac J Cancer Prev 2010;11:1045-9.
  • 3 Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76.
  • 4 Dewolf L, Koller M, Velikova G, Johnson C, Scott N, Bottomley A on behalf of the EORTC Quality of Life Group. EORTC Quality of Life Group Translation Procedure. 3rd ed. EORTC Quality of Life Group Publication, Brussels 2009. (ISBN 978-2-930064-38-3).
  • 5 Available from: http://www.groups.eortc.be/qol/eortc-qlq-c30. [Last accessed on 2017 Sep 10].
  • 6 Greimel E, Bottomley A, Cull A, Waldenstrom AC, Arraras J, Chauvenet L, et al. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer. Eur J Cancer 2003;39:1402-8.